Clinical Trial Update: Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)

View source ↗

Summary

A clinical trial update for ONCO-RD 010 CRT indicates the tumor marker study in gastric cancer is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Seoul National University Hospital | Conditions: Stomach Neoplasms | Status: SUSPENDED